The World Health Organization’s July 23, 2022, declaration of a public health emergency of international concern did not mark the beginning of the mpox outbreak. Instead, it served as formal recognition of a crisis that had been developing over an extended period. The virus, previously known as monkeypox, had been circulating and undergoing changes within human populations for years before the first case was identified in the United Kingdom on May 6, 2022.
That initial patient, a London resident who had recently traveled from Nigeria, represented only the visible portion of a larger, more complex situation. On May 16, the UK Health Security Agency confirmed four additional cases.
None of these patients had traveled to countries where mpox is endemic. This development fundamentally altered scientific understanding of the disease. Human-to-human transmission had moved from a theoretical possibility to a confirmed reality.
The outbreak was driven by the clade IIb variant. Unlike the virus that had historically made sporadic jumps from animals to humans in West and Central Africa over decades, this version had adapted for sustained spread among people.
This adaptation occurred quietly over several years. Following identification of the first cases, global dissemination happened rapidly. Nations with no prior connection to mpox began reporting infections. The disease crossed international boundaries faster than public health surveillance systems could monitor it.
WHO Director-General Tedros Adhanom Ghebreyesus called for coordinated international action. The emergency declaration granted him authority to push for such a response.
However, by July 23, the virus had already reached multiple continents. The subsequent public health interventions—including surveillance, contact tracing, and targeted vaccination—were reactive measures. They aimed to contain something that had already escaped containment.
The UKHSA’s early detection work proved critical. Identifying those initial four cases without travel links served as an alarm.
It indicated to health officials that community transmission was occurring. But that alarm sounded after the virus had already been circulating and evolving among humans for years. The chronology matters.
The outbreak did not begin in May 2022. That was when global attention turned to it.
The WHO’s response focused on reducing transmission and coordinating international efforts. Yet the fundamental problem persisted. A viral disease once confined to specific geographic regions had broken out of its ecological niche.
The clade IIb variant demonstrated capacity for ongoing human-to-human transmission. Research into transmission patterns remained limited when the emergency was declared.
This outbreak marked the first time mpox spread extensively outside Central and West Africa, making it a global health concern. The deeper story involves a virus that had been evolving, adapting, and waiting. The emergency declaration represented a milestone, but also an admission.
The world was catching up to a problem that had been growing for years. Public health responses depend on the surveillance systems that support them.
The UKHSA’s detection work was effective. The WHO’s coordination was necessary. But neither could reverse the years of undetected spread that preceded the first official case. The outbreak was already underway.
The declaration simply made it official.
